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ABSTRACT
PARSONS, T. J., C. SARTINI, P. WELSH, N. SATTAR, S. ASH, L. T. LENNON, S. G. WANNAMETHEE, I-M. LEE, P. H.
WHINCUP, and B. J. JEFFERIS. Physical Activity, Sedentary Behavior, and Inflammatory and Hemostatic Markers in Men. Med. Sci.
Sports Exerc., Vol. 49, No. 3, pp. 459–465, 2017. Purpose: This study aimed to determine whether higher levels of physical activity
(PA) and less sedentary behavior (SB) are associated with less inflammation, indicated by inflammatory and hemostatic biomarkers, in
older men. Methods: A cross-sectional study of 1139 men, from the British Regional Heart Study (mean T SD age = 78 T 5 yr), and
longitudinal analyses of 490 men with two PA measures 1 yr apart were used in this study. Single fasting venous blood samples were
analyzed for several biomarkers. PA and SB were measured using ActiGraph GT3X accelerometers. Total time and time spent in bouts of
moderate to vigorous PA (MVPA), light PA, and SB were derived. Linear regression analyses were used to investigate associations.
Results: Cross-sectionally, higher total PA, daily steps, and MVPA were all associated with lower levels of interleukin 6 (IL-6), C-reactive
protein (CRP), tissue plasminogen activator (tPA), von Willebrand factor (vWF), and D-dimer, whereas higher levels of SB were associated
with higher levels of IL-6, CRP, and tPA. Each additional 10 min of MVPAwas associated with a 3.2% lower IL-6 (95% confidence interval
[CI] =j4.5% toj1.8%), 5.6% lower CRP (95%CI =j7.8 toj3.3), 2.2% lower tPA (95%CI =j3.0 toj1.4), 1.2% lower vWF (95%CI =
j2.1 to j0.3), and 1.8% lower D-dimer (95% CI = j2.9 to j0.7), and for CRP, vWF, and D-dimer independently of SB. Associations
between SB and IL-6 or tPA were independent of MVPA. Longer bouts of PA or SB were not more strongly associated with outcomes than
shorter bouts. Longitudinal analyses were inconsistent with these findings, possibly because of power limitations. Conclusion:
Although PA (particularly MVPA) was generally associated with inflammatory and hemostatic biomarkers, we found no evidence that longer
bouts were more important than shorter bouts. Key Words: EPIDEMIOLOGY, CARDIOVASCULAR DISEASE, COAGULATION,
HEMOSTASIS, BIOMARKERS
T
he aging process is associated with decreasing levels
of physical activity (PA) (30) and increasing levels
of inflammatory (29) and hemostatic (22,32,33) markers
and insulin-like growth factor 1 (IGF-1) (2,31), all of which
have been linked to major age-related degenerative diseases
such as cardiovascular disease (CVD) and type 2 diabetes.
Interleukin 6 (IL-6), for example, which rises steeply with
age (12,34), has been shown to be particularly strongly
linked to fatal CHD in older adults (29). The levels of sev-
eral hemostatic factors also increase with age; tissue plas-
minogen activator (tPA) and D-dimer, markers of fibrinolytic
activity, and von Willebrand factor (vWF), a marker of co-
agulation and endothelial dysfunction (34), and the balance of
these factors is important because they are associated with
increased risk of CHD events (22,32,33). The inflammatory
and coagulation systems potentially interact; increased in-
flammation can increase coagulation that in turn promotes
inflammation, such that the systems can exert positive feed-
back on one another. IGF-1, a hormone stimulating cell
growth and proliferation, is generally considered to have a
protective effect on the cardiovascular system and declines
with age (31). Several studies have reported lower IGF-1
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levels to be prospectively associated with increased CVD risk
(31), although recent findings suggest this relationship may be
U-shapedwith both low and high levels increasing CVD risk (2).
Observational studies of how PA relates to inflammatory
and hemostatic markers have been mostly based on self-
reported PA data, and on middle-age rather than older adults
(14,19,23,28). This literature is consistent in that lower levels
of PA are related to an adverse inflammatory profile and in-
creased levels of hemostatic markers, but self-report data are
limited in detecting light activities and sedentary behavior
(SB), which predominate in older age (16,18). Furthermore,
they cannot accurately quantify the patterns of activity, e.g.,
whether activity is sustained in bouts of a particular duration.
Intervention studies of exercise training, mostly on C-reactive
protein (CRP), have shown inconsistent results and suggest
that the relative contributions of PA and weight loss on CRP
are unclear (21,25). A review of exercise training specifically
as part of cardiac rehabilitation programs and in older adults
concluded that exercise training in this population was
beneficial to a wide range of clinical factors including in-
flammation (24).
This study therefore aims to better quantify, in a sample of
community-dwelling older men, associations between objec-
tively measured PA and SB, and the inflammatory markers
CRP and IL-6, hemostatic markers tPA, vWF and D-dimer,
and IGF-1. We investigated associations for different intensi-
ties of PA, including moderate and vigorous activities, light
activities and SB, and whether these associations were inde-
pendent.We also examined the importance of bouts of activity
of different durations, i.e., whether benefits are only accrued
from accumulating activity in bouts of 10 min or more as
stipulated for moderate to vigorous PA (MVPA) in the current
PA guidelines (9). In addition, we examined longitudinal re-
lationships between changes in PA and SB for 1 yr and the
previously mentioned biomarkers in a subset of men.
METHODS
Sample. The British Regional Heart Study is a population-
based cohort study following up 7735 men (999% white
European) recruited from primary care practices in 24 British
towns in 1978–1980. In 2010–2012, 3137 surviving men
were invited to a physical examination, and from 2010
onward, men were asked to wear an accelerometer at yearly
intervals; one of these occasions coincided with the physical
examination. The National Research Ethics Service Committee
London provided ethical approval. Participants provided in-
formed written consent to the investigation in accordance with
the Declaration of Helsinki.
Inflammatory and hemostatic biomarkers. Fasting
venous blood samples were analyzed for IL-6 (pgImLj1),
CRP (mgILj1), tPA (ngImLj1), vWF (IUIdLj1), D-Dimer
(ngImLj1), and IGF-1 (ngImLj1). CRP was assayed using
ultrasensitive assay on an automated clinically validated analyzer
(e411; Roche, Burgess Hill, UK) using the manufacturer_s
calibrators and controls (coefficient of variation 6.9%). Plasma
levels of high-sensitivity IL-6 and IGF-1 (R&D Systems,
Oxon, UK), tPA and D-dimer (Asserachrom assays; Stago,
Theale, UK), and vWF antigen (Technozym assay; Pathway
Diagnostics, Dorking, UK)weremeasured using enzyme-linked
immunosorbent assays. Intra- and interassay coefficients of
variation, respectively, were as follows: 5.9% and 11.6% (IL-
6), 5.5% and 4.1% (tPA), 14.1% and 14.3% (vWF), 5.4% and
3.2% (D-dimer), and 4.4% and 7.0% (IGF-1).
Physical activity. Men wore the GT3X accelerometer
(ActiGraph, Pensacola, FL) over the right hip for 7 d, during
waking hours, removing it for swimming or bathing. Data
were processed using standard methods (17). Nonwear time
was excluded using the R package ‘‘physical activity’’ (3).
Valid wear days were defined by convention as Q600 min
wear time, and participants with Q3 valid days were included
in analyses. Each minute of activity was categorized using
intensity threshold values of counts per minute developed
for older adults: G100 for SB (G1.5 MET), 100–1040 for light
PA (LPA) (1.5–3MET), and 91040 for MVPA,(Q3MET) (6).
Other study variables. Body mass index (BMI, kgImj2)
was calculated from height (Harpenden Stadiometer) and
weight in light indoor clothing (Tanita body composition an-
alyzer (BC-418) or Tanita scales if the participant had a
pacemaker or defibrillator). Participants completed a ques-
tionnaire, including information about current cigarette
smoking, alcohol consumption, living alone, current use of an-
tihypertensives, statins and anticoagulants, ever receiving a
doctor diagnosis of heart attack, and heart failure or stroke (with
symptoms lasting 924 h). Social class was based on longest held
occupation at study entry (1978–1980), categorized as manual
and nonmanual (27). Region of residence (1978–1980) was
grouped into Scotland, North, Midlands, and South of England.
Statistical methods. Men reporting a diagnosis of heart
attack, heart failure, or stroke (with symptoms lasting 924 h)
were excluded from analyses. Descriptive statistics for
demographic characteristics, inflammatory and hemostatic
markers (raw values), PA, and SB were calculated by quartile
of daily minutes of MVPA and SB. Associations between
each of the different PA measures and each biomarker were
investigated in a series of linear regression models. The PA
exposures we investigated were total activity counts per day,
steps per day, and minutes per day of SB, LPA and MVPA.
The distributions of CRP, IL-6, tPA, vWF, and D-dimer were
right skewed and therefore transformed using natural loga-
rithm. For ease of interpretation, we estimated regression co-
efficients for each 10,000 counts of total activity, 1000 steps,
30 min of SB or LPA, and 10 min of MVPA and present
results as percentage difference in biomarker levels derived
from these regression analyses. To evaluate the independence
of associations of activity intensities, models were mutually
adjusted: (i) MVPA and SB and (ii) MVPA and LPA in the
same model. SB and LPA were not included simultaneously
because of collinearity (r = j0.62). We investigated associ-
ations between biomarkers and number of minutes accumu-
lated in bouts of MVPA, LPA, or SB for the following PA
bout durations: SB lasting 1–15, 16–30, 31–60, and Q61 min;
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LPA 1–9 and Q10min; andMVPA 1–9 and Q10min. Durations
of MVPA bouts were chosen to reflect current guidelines (9),
but in the absence of recommendations for SB and LPA, bout
durations were chosen based on their distributions. All models
were adjusted for average accelerometer wear time (minIdj1),
season of accelerometer wear (warm, May–September, or
cold, October–April), hour of blood sampling, age, region of
residence, social class, living alone, smoking status, and al-
cohol consumption. Wear time varied markedly, and because
wearing the accelerometer for longer periods allows a partic-
ipant to accumulate more minutes of PA and SB, we included
wear time in models to account for wear time variability. For
all models including D-dimer, we excluded men taking anti-
coagulants (British National Formulary code 2.8.2) (1).
Finally, a subgroup of men (approximately 40%) had ac-
celerometer data both 1 yr before (time 1) and at the time of
(time 2) the physical examination (including blood sampling).
As exploratory analyses, we investigated the relationship be-
tween change in PA/SB (time 1 to time 2) and biomarker level
at time 2 (log transformed as described earlier). Linear re-
gression models included mean activity (mean of time 1 and
time 2) and change in activity (time 1 to time 2) and were
adjusted for both mean and change in accelerometer wear
time, mean age, number of days between time 1 and time 2,
season (three categories: cold at both time points, warm at
both time points, and different at each time point), region of
residence, social class, living alone, smoking, and alcohol
consumption. We present results as percentage change in
biomarker per specified increase in PA or SB.
We further adjusted all models (cross-sectional and lon-
gitudinal) for BMI to investigate the effect of BMI on the
relationships between PA/SB and the biomarkers. MVPA
minutes were right skewed, so we repeated regression models
using square root transformed MVPA.
RESULTS
We invited 3137 men to the physical examination; 1722
(55%) attended, of whom 291 with preexisting heart disease
were excluded, as were a further 157 men who either did not
wear an accelerometer or did not have valid data, leaving
1274 men. We excluded 65 men who were taking antico-
agulants from D-dimer analyses. Our main analyses included
1070–1139 men (depending on biomarker) with complete
data for cross-sectional analysis and 455–490 men for longi-
tudinal analysis. Of men who were invited to the examination,
those with complete data had a lower BMI 10 yr earlier (26.6 vs
27.2 kgImj2) and were more active (59% vs 48% at least
moderately active) than those who did not attend or have
complete data. Men had a mean of 4938 steps and 164,749
accelerometer counts per day (Table 1) and spent on average
616, 199, and 40 min of their time in SB, LPA, and MVPA,
respectively. Men who spent more time in MVPA were
younger, had a lower BMI, consumed more alcohol, and were
less likely to smoke or take statins, antihypertensives, or an-
ticoagulants or have diabetes (Table 1). Relationships with
SB were in the opposite direction such that men who spent
more time in SB were older, had a higher BMI, and were
more likely to live alone, smoke, take statins or antihyper-
tensives, or have diabetes (see Table, Supplemental Digital
Content 1, Characteristics of 1274 men without preexisting
CVD or heart failure, by quartile of minutes per day spent in
TABLE 1. Characteristics of 1274 men without preexisting CVD or heart failure, by quartile of minutes per day spent in MVPA.
Quartile of MVPA (minIdj1)
1 2 3 4
Mean (SE) or % (n) 0.4–G3.1a Q3.1–G30.8a Q30.8–G53.5a Q53.5a P (Trend) All Men N
Na 291 308 340 335 1274
Age, mean T SE (yr) 81.0 T 5.0 78.7 T 4.7 77.8 T 4.0 76.5 T 3.5 G0.0001 78.4 T 4.6 1274
Manual Social class, n (%) 150 (52) 139 (45) 154 (45) 151 (46) 0.29 594 (47) 1266
Lives alone, n (%) 65 (23) 59 (19) 62 (19) 52 (16) 0.18 238 (19) 1256
Smoker, n (%) 19 (6.6) 14 (4.6) 5 (1.5) 7 (2.1) 0.002 45 (3.5) 1257
Taking statins, n (%) 156 (54) 136 (44) 150 (44) 129 (39) 0.002 571 (45) 1274
Taking antihypertensives, n (%) 192 (66) 167 (54) 187 (55) 144 (43) G0.0001 690 (54) 1273
Taking anticoagulants, n (%) 23 (7.9) 20 (6.5) 14 (4.1) 14 (4.2) 0.1 71 (5.6) 1274
Diabetic, n (%) 63 (22) 33 (11) 49 (14) 34 (10) G0.0001 179 (14) 1273
Alcohol (units per week) 5.2 T 7.3 6.0 T 7.7 6.8 T 7.5 7.2 T 7.9 G0.0001 6.4 T 7.6 1240
BMI (kgImj2) 23.2 T 4.6 27.4 T 3.6 26.9 T 3.6 26.1 T 3.1 G0.0001 27.1 T 3.8 1263
IL-6 (pgImLj1)b 4.30 T 2.15 3.00 T 1.88 2.64 T 1.99 2.50 T 2.09 G0.0001 2.99 T 2.08 1195
CRP (mgILj1)b 2.16 T 3.40 1.39 T 2.98 1.23 T 3.15 0.97 T 3.12 G0.0001 1.34 T 3.26 1183
tPA (ngImLj1)b 10.06 T 1.55 9.33 T 1.52 8.77 T 1.54 8.26 T 1.57 G0.0001 9.03 T 1.55 1190
vWF (IUIdLj1)b 129.80 T 1.59 117.65 T 1.58 113.94 T 1.61 110.42 T 1.63 G0.0001 117.22 T 1.61 1190
D-dimer (ngImLj1)b,c 314.11 T 1.94 228.49 T 1.79 228.02 T 1.80 198.83 T 1.69 G0.0001 235.59 T 1.84 1125
IGF-1 (ngImLj1) 72.77 T 24.12 75.70 T 22.45 77.11 T 23.88 78.06 T 23.08 0.006 76.08 T 23.63 1185
Accelerometer wear time (minIdj1) 826 T 71 850 T 63 863 T 65 876 T 64 G0.0001 855 T 68 1274
Total activity (counts per day) 61,669 T 24,590 113,645 T 23.416 171,554 T 29,976 294,370 T 83,994 G0.0001 164,749 T 99,272 1274
Steps per day 1895 T 883 3645 T 832 5302 T 1022 8401 T 2370 G0.0001 4938 T 2794 1274
SB (minIdj1) 676 T 76 638 T 65 607 T 68 552 T 76 G0.0001 616 T 84 1274
LPA (minIdj1) 144 T 56 189 T 50 214 T 52 239 T 61 G0.0001 199 T 65 1274
MVPA (minIdj1) 7 T 22 22 T 5 41 T 6 85 T 27 G0.0001 40 T 33 1274
Pearson chi-square test was used for all categorical variables except smoking for which Fisher exact test was used.
aMaximum N in quartile, varies slightly with missing covariate data.
bGeometric means given.
cMen taking anticoagulants excluded.
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SB, http://links.lww.com/MSS/A774). MVPA was correlated
with LPA, r = 0.50, and LPA with SB, r = j0.62, both
P G 0.0001.
PA, SB, and biomarkers: cross-sectional
analyses. Men who spent more time in MVPA had lower
levels of IL-6, CRP, tPA, vWF, and D-dimer and higher
levels of IGF-1 (P e 0.006, Table 1). Conversely, men with
higher levels of SB had higher levels of IL-6, CRP, tPA, and
D-dimer and lower levels of IGF-1 (P e 0.03; see Table,
Supplemental Digital Content 1, Characteristics of 1274 men
without preexisting CVD or heart failure, by quartile of
minutes per day spent in SB, http://links.lww.com/MSS/
A774). In regression models adjusted for covariates, higher
total PA, daily steps, and MVPA were all associated with
lower levels of IL-6, CRP, tPA, vWF, and D-dimer (Table 2,
models 1–3). Each additional 10 min of MVPA was associ-
ated with a 3.2% lower IL-6, 5.6% lower CRP, 2.2% lower
tPA, 1.2% lower vWF, and 1.8% lower D-dimer, all P G 0.05
(Table 2, Model 3). Each extra 30 min of LPA per day was
associated with a lower IL-6, CRP, and tPA; LPA coefficients
were 30%–50% smaller than MVPA (when MVPA co-
efficients were multiplied by 3, to also relate to 30-min
increments) (Table 2, model 4). Associations between SB
and IL-6, CRP, and tPA were in the opposite direction to
those with LPA but of similar size (Table 2, model 5).
LPA and SB were unrelated to vWF or D-dimer and none
of the PA variables were associated with IGF-1.
When MVPA was included in the same model as SB
(Table 2, model 6), associations between MVPA and bio-
markers persisted for CRP (magnitude slightly reduced),
vWF (coefficient unchanged but of borderline significance),
and D-dimer (association strengthened), but not for IL-6 and
tPA, whereas when MVPA was included in the same model
as LPA (Table 2, model 7), all MVPA coefficients persisted,
although slightly attenuated. In these latter models (Table 2,
model 7), associations between LPA and IL-6 or tPA (but
not for CRP) also persisted although reduced in magnitude.
In models including MVPA and SB, associations between SB
and IL-6 or tPA persisted, albeit with some reduction (Table 2,
model 6). Additional adjustment for diabetes or use of anti-
hypertensive medication or statins did not change results.
After adjusting for BMI, the coefficients for the associations
between PA/SB and CRP or tPA were attenuated (20%–50%
for CRP and approximately 50% for tPA), although all asso-
ciations remained significant except between SB and tPA
when MVPA was included (see Table, Supplemental Digital
Content 2, Cross-sectional associations between physical ac-
tivity intensity, sedentary time, and biomarkers, with addi-
tional adjustment for BMI, http://links.lww.com/MSS/A775).
Associations between PA/SB and IL-6 were reduced to a
lesser extent (15%–30%), whereas associations with vWF
and D-dimer were little changed and all remained significant.
Associations were essentially unchanged when models were
repeated using square root transformed MVPA.
Bouts of SB and PA. MVPA lasting Q10 min was rel-
atively uncommon; 31% accumulated Q5 bouts per week TA
BL
E
2.
Cr
os
s-
se
ct
io
na
la
ss
oc
ia
tio
ns
be
tw
ee
n
PA
in
te
ns
ity
,s
ed
en
ta
ry
tim
e,
an
d
bi
om
ar
ke
rs
.
ln
IL
-6
N
=
11
39
ln
CR
P
N
=
11
29
ln
tP
A
N
=
11
33
ln
vW
F
N
=
11
33
ln
D
-d
im
er
N
=
10
70
a
IG
F-
1
N
=
11
31
%
D
iff
er
en
ce
(9
5%
CI
)
%
D
iff
er
en
ce
(9
5%
CI
)
%
D
iff
er
en
ce
(9
5%
CI
)
%
D
iff
er
en
ce
(9
5%
CI
)
%
D
iff
er
en
ce
(9
5%
CI
)
%
D
iff
er
en
ce
(9
5%
CI
)
M
od
el
1
To
ta
lv
er
tic
al
co
un
ts
(p
er
10
,0
00
Id
j
1 )
j
1.
3
(j
1.
8
to
j
0.
9)
j
2.
1
(j
2.
9
to
j
1.
4)
j
0.
8
(j
1.
1
to
j
0.
6)
j
0.
4
(j
0.
7
to
j
0.
1)
j
0.
6
(j
1.
0
to
j
0.
2)
3.
4
(j
12
.2
to
18
.9
)
M
od
el
2
st
ep
s
(p
er
10
00
Id
j
1 )
j
4.
9
(j
6.
6
to
j
3.
3)
j
8.
2
(j
10
.9
to
j
5.
5)
j
2.
7
(j
3.
7
to
j
1.
7)
j
1.
8
(j
2.
9
to
j
0.
7)
j
2.
8
(j
4.
2
to
j
1.
5)
13
.9
(j
41
.6
to
69
.4
)
M
od
el
3
To
ta
lM
VP
A
(p
er
10
m
in
Id
j
1 )
j
3.
2
(j
4.
5
to
j
1.
8)
j
5.
6
-(
7.
8
to
j
3.
3)
j
2.
2
(j
3.
0
to
j
1.
4)
j
1.
2
(j
2.
1
to
j
0.
3)
j
1.
8
(j
2.
9
to
j
0.
7)
14
.9
(j
30
.9
to
60
.7
)
M
od
el
4
To
ta
lL
PA
(p
er
30
m
in
Id
j
1 )
j
6.
0
(j
8.
1
to
j
3.
8)
j
5.
0
(j
8.
6
to
j
1.
3)
j
2.
9
(j
4.
1
to
j
1.
6)
j
0.
8
(j
2.
2
to
0.
6)
0.
2
(j
1.
6
to
2.
0)
j
24
.6
(j
97
.7
to
48
.5
)
M
od
el
5
To
ta
lS
B
(p
er
30
m
in
Id
j
1 )
5.
1
(3
.5
to
6.
8)
5.
8
(3
.3
to
8.
6)
2.
8
(1
.8
to
3.
8)
1.
1
(j
0.
0
to
2.
2)
0.
8
(j
0.
6
to
2.
2)
7.
2
(j
49
.3
to
63
.7
)
M
od
el
6
To
ta
lM
VP
A
(p
er
10
m
in
Id
j
1 )
j
0.
5
(j
2.
4
to
1.
4)
j
4.
5
(j
7.
6
to
j
1.
3)
j
1.
1
(j
2.
3
to
0.
0)
j
1.
2
(j
2.
4
to
0.
1)
j
2.
7
(j
4.
2
to
j
1.
1)
36
.7
(j
27
.1
to
10
0.
4)
To
ta
lS
B
(p
er
30
m
in
Id
j
1 )
4.
7
(2
.4
to
7.
1)
2.
0
(j
1.
9
to
5.
8)
1.
8
(0
.4
to
3.
2)
0.
1
(j
1.
5
to
1.
6)
j
1.
5
(j
3.
4
to
0.
5)
38
.6
(j
40
.0
to
11
7.
2)
M
od
el
7
To
ta
lM
VP
A
(p
er
10
m
in
Id
j
1 )
j
2.
0
(j
3.
5
to
j
0.
6)
j
5.
1
(j
7.
6
to
j
2.
7)
j
1.
7
(j
2.
6
to
j
0.
9)
j
1.
2
(j
2.
2
to
j
0.
2)
j
2.
2
(j
3.
4
to
j
1.
0)
23
.8
(j
25
.5
to
73
.1
)
To
ta
lL
PA
(p
er
30
m
in
Id
j
1 )
j
4.
7
(j
7.
1
to
j
2.
4)
j
2.
0
(j
5.
8
to
1.
1)
j
1.
8
(j
3.
2
to
j
0.
4)
j
0.
1
(j
1.
6
to
1.
5)
1.
5
(j
0.
5
to
3.
4)
j
38
.6
(j
11
7.
2
to
40
.0
)
Es
tim
at
es
pr
ov
id
ed
ar
e
pe
rc
en
ta
ge
di
ffe
re
nc
es
(9
5%
CI
)
in
bi
om
ar
ke
r
le
ve
ls
fo
r
sp
ec
ifi
ed
in
cr
ea
se
s
in
PA
or
se
de
nt
ar
y
tim
e
pa
ra
m
et
er
,d
er
iv
ed
fro
m
lin
ea
r
re
gr
es
si
on
an
al
ys
es
.
Bo
ld
te
xt
in
di
ca
te
s
di
ffe
re
nc
es
th
at
ar
e
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
(P
G
0.
05
).
Al
lm
od
el
s
ar
e
ad
ju
st
ed
fo
r
av
er
ag
e
da
ily
ac
ce
le
ro
m
et
er
w
ea
r
tim
e,
se
as
on
of
w
ea
r,
ho
ur
of
bl
oo
d
sa
m
pl
in
g,
re
gi
on
of
re
si
de
nc
e,
ag
e,
so
ci
al
cl
as
s,
liv
in
g
al
on
e,
to
ba
cc
o,
an
d
al
co
ho
lc
on
su
m
pt
io
n.
CI
,c
on
fid
en
ce
in
te
rv
al
.
a M
en
ta
ki
ng
an
tic
oa
gu
la
nt
s
ex
cl
ud
ed
.
http://www.acsm-msse.org462 Official Journal of the American College of Sports Medicine
EP
ID
EM
IO
LO
G
Y
and 12% accumulated Q10 bouts per week. Regressionmodels
examining associations between number of minutes accumu-
lated in bouts of MVPA, LPA, or SB of particular lengths and
each biomarker showed no consistent evidence that accumu-
lating activity in bouts of shorter (or longer) lengths was
associated with these measures (Table 3).
Longitudinal analyses. In the subset of 455–490 men
with longitudinal data, the mean time between PA measures
was 327 d (10.8 months). The changes in percentage of time
per day spent in MVPA, LPA, and SB between time 1 and
time 2 werej0.1% (SD 2.5%), LPAj0.1% (4.2%), and SB
0.3% (5.4%), respectively (percentages account for changes
in wear time). In general, associations between the biomarkers
and the mean of the PA variables at time 1 and time 2
(see Table, Supplemental Digital Content 3, Associations be-
tween change in physical activity and sedentary time between
time 1 and time 2, and biomarkers at time 2 in 490 men, http://
links.lww.com/MSS/A776) reflected the cross-sectional re-
lationships (Table 2), although in the longitudinal subset the
magnitude of these associations was increased for tPA, vWF,
and D-dimer. Changes in activity over time were associated
with vWF and IL-6; an increase in LPA of 30 minIdj1 be-
tween time 1 and time 2 was associated with a 3.9% decrease
in vWF (see Table, Supplemental Digital Content 3, Associ-
ations between change in physical activity and sedentary time
between time 1 and time 2, and biomarkers at time 2 in 490
men—model 4, http://links.lww.com/MSS/A776), whereas
an increase in SB was associated with a 2.8% increase in
vWF and a 4.4% decrease in IL-6 (see Table, Supplemental
Digital Content 3, Associations between change in physical
activity and sedentary time between time 1 and time 2, and
biomarkers at time 2 in 490 men—model 5, http://links.lww.
com/MSS/A776). Adjusting for BMI reduced the magnitude
and significance of the association between change in SB
and IL-6.
DISCUSSION
In this study of older community-dwelling men, we found
that higher levels of total PA, MVPA, and LPA were associ-
ated with lower levels of IL-6 and CRP, i.e., a more favorable
inflammatory profile. Conversely, higher levels of SB were
associated with higher levels of these inflammatory markers.
Among the hemostatic markers, this pattern of associations
was also seen for tPA, whereas for vWF and D-dimer, only
total PA and MVPA (not LPA or SB) were associated with
marker levels. We found some evidence that associations
between biomarkers and PA were independent of SB and
vice versa, although this was not entirely consistent across
inflammatory or hemostatic markers; associations between
MVPA and CRP, vWF, or D-dimer were independent of SB
or LPA (borderline significance in the case of MVPA and
vWF adjusted for SB), whereas for IL-6 and tPA, the associ-
ation with SB was independent of MVPA, and associations
with MVPA and LPA were independent of each other. Our
findings are consistent with previous studies; higher levels of TA
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PA were associated with lower levels of inflammatory and
hemostatic markers (5,11,19,23,26). In our study, BMI re-
duced magnitude of associations between PA/SB and CRP,
tPA, and IL-6, not unexpectedly because BMI is directly re-
lated to inflammatory marker levels and adipose tissue is a
source of IL-6 production. Although some studies report that
BMI attenuates associations (5,11), not all do (26). We found
no evidence that accumulating PA in longer bouts was of
greater benefit than shorter bouts, but we acknowledge that
our statistical power may be limited in this respect.
Strengths and limitations. The major strengths of our
study are (i) the presentation of relationships between objec-
tively measured PA of different intensities, SB, and a range of
inflammatory and hemostatic biomarkers and (ii) the exami-
nation of the importance of activity accumulated in bouts of
different lengths relating to current PA guidelines. The men in
our study are from a less-studied older age-group and a pop-
ulation sample that increases generalizability, although pos-
sibly not to younger ages or women. Although men who
participated in our study were healthier than those who did
not, given the wide range of activity levels among participants,
we would not anticipate any bias in average level of activity to
affect our estimation of associations between activity and
biomarkers. As is typical in older populations, amounts of
moderate and vigorous activity were small, and we therefore
present them combined, which also allows comparison with
other studies. The ActiGraph accelerometer is validated for
measuring low levels of energy expenditure but lacks good
inclinometer data to differentiate standing and sitting during
periods of G100 counts per minute. However, the mean value
of these minutes was G10 counts per minute, suggesting that
SB time was very sedentary. Our response rate for agreeing to
wear an accelerometer was 51% (17), greater than rates
reported in other UK studies of older adults (7,8), and ad-
herence to the 7 d accelerometer wear protocol was high, with
96% of men providing the Q5 d of data needed to predict
habitual PA/SB (15). We were able to adjust for a range of
potential confounding factors, although we are unable to es-
tablish the direction of effect from our cross-sectional analy-
ses. We explored direction of effect in longitudinal analyses,
but our findings for associations between 1 yr change in PA/
SB and marker levels were not consistent with our cross-
sectional findings, possibly partly because of the small changes
in PA and SB. Given the small sample size and limited follow-
up period, we consider these to be secondary analyses which
require further investigation in larger studies.
Implications of findings. Physical activity may exert
its protective effect on CVD in part through anti-
inflammatory effects and by influencing hemostatic factors.
Inflammation has been linked to CVD, insulin resistance,
chronic obstructive pulmonary disease, some cancers, dementia,
and depression, and PA has been associated with a decreased
risk of these conditions (13). The activation of the coagulation
system and the resulting increase in hemostatic markers have
been implicated in the development of atherosclerosis, and
higher levels of markers such as D-dimer have been associated
with greater declines in physical function (4). The inflamma-
tory and coagulation pathways become more active with ag-
ing and potentially exert positive feedback on each other. For
example, D-dimer stimulates the synthesis and release of
proinflammatory cytokines, including IL-6, which promotes
CRP, coagulation factor, and platelet synthesis and contrib-
utes to endothelial dysfunction (10,20). PA reduces CRP
levels via multiple possible mechanisms, including a decrease
in cytokine production by adipose tissue and skeletal muscle,
improved endothelial function and insulin sensitivity, and an
antioxidant effect.
Our study shows PA, in particular MVPA, to be associ-
ated with more favorable profiles of inflammatory and he-
mostatic markers, which identify risk for CVD and other
chronic age-related diseases. In our data, longer bouts of PA
or SB were not more strongly associated with biomarkers
than shorter bouts. In longitudinal analyses, increases in PA
were beneficial only for vWF, and interestingly, it was LPA
and SB showing this association (an increase SB being
detrimental), suggesting they too may have relevance, al-
though further studies are needed. Given the decline in PA
in aging populations, PA is an important potential modifier
of adverse inflammatory and hemostatic risk profiles.
CONCLUSION
In community-dwelling older British men, objectively
measured PA showed beneficial associations and SB detri-
mental associations with inflammatory and hemostatic bio-
markers, including IL-6, CRP, tPA, vWF, and D-dimer.
Adverse profiles of these markers have been linked to several
major age-related degenerative diseases ranging from CVD to
dementia. This is the first study to investigate associations
between a range of biomarkers and objectively measured PA,
including different intensities (MVPA, LPA, and SB) and
number of minutes per day accumulated in bouts of specific
durations, about national PA guidelines. We found no evi-
dence that the bout length of PA or SB was important for the
biomarkers we examined. Our findings indicate that all ac-
tivity matters, particularly MVPA. Current guidelines recom-
mend that MVPA is accumulated in bouts of at least 10 min;
therefore, our findings are relevant for considerations of future
guideline refinements. PA may be an important potential
modifier of adverse inflammatory and hemostatic risk profiles.
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